Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer
Status:
Recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of PD-L1/CTLA4 BsAb for the second line treatment and the
combination with chemotherapy for the first line treatment in pancreatic cancer